investorscraft@gmail.com

Intrinsic ValueRenaissance,Incorporated (2378.T)

Previous Close¥1,089.00
Intrinsic Value
Upside potential
Previous Close
¥1,089.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2025 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Renaissance, Incorporated operates as a diversified sports and wellness services provider in Japan, focusing on fitness clubs, swimming schools, tennis schools, and golf schools. The company has expanded its offerings to include health promotional services for municipalities and corporations, nursing care and rehabilitation support, and small-scale facility expansion services. Its Synapsology program, a brain activation method, further diversifies its wellness portfolio. Positioned in the consumer cyclical sector, Renaissance leverages Japan’s aging population and growing health consciousness to drive demand for its services. The company’s integrated approach—combining physical fitness, rehabilitation, and cognitive health—differentiates it from traditional gym operators. Its partnerships with local governments and corporations provide stable revenue streams, while its niche in brain activation methods offers potential for higher-margin growth. Despite operating in a competitive industry, Renaissance maintains a regional stronghold with a focus on holistic wellness solutions.

Revenue Profitability And Efficiency

Renaissance reported revenue of JPY 43.6 billion for FY 2024, with net income of JPY 633 million, reflecting modest profitability in a capital-intensive industry. Operating cash flow stood at JPY 4.8 billion, indicating reasonable operational efficiency, though capital expenditures of JPY 2.2 billion suggest ongoing investments in facility upgrades and expansion. The company’s ability to generate positive cash flow despite high fixed costs underscores its disciplined cost management.

Earnings Power And Capital Efficiency

The company’s diluted EPS of JPY 30.94 highlights its earnings capacity, though its capital efficiency is constrained by significant debt (JPY 27.3 billion) relative to cash reserves (JPY 6.2 billion). The low beta of 0.45 suggests resilience to market volatility, but high leverage may limit financial flexibility. Operating cash flow coverage of debt service remains a critical metric for sustainability.

Balance Sheet And Financial Health

Renaissance’s balance sheet reflects a leveraged position, with total debt of JPY 27.3 billion outweighing cash and equivalents of JPY 6.2 billion. While the company’s market capitalization of JPY 19.1 billion provides some equity cushion, its debt-heavy structure necessitates careful liquidity management. The ability to service debt through operating cash flow will be pivotal for maintaining financial stability.

Growth Trends And Dividend Policy

Growth appears steady but not explosive, with revenue stability supported by long-term contracts in municipal and corporate wellness services. The dividend payout of JPY 4 per share indicates a conservative distribution policy, likely prioritizing debt reduction and reinvestment. Demographic trends in Japan favor sustained demand for health and rehabilitation services, but competition may pressure margins.

Valuation And Market Expectations

With a market cap of JPY 19.1 billion, Renaissance trades at a moderate valuation relative to its revenue base. Investors likely price in steady, low-growth cash flows given the company’s niche market position and leveraged balance sheet. The low beta suggests the stock is perceived as a defensive play within the consumer cyclical sector.

Strategic Advantages And Outlook

Renaissance’s strategic advantage lies in its diversified wellness ecosystem, which mitigates reliance on any single service line. Partnerships with public and private entities provide recurring revenue, while Synapsology offers innovation potential. However, high debt and competitive pressures pose risks. The outlook remains cautiously optimistic, contingent on effective deleveraging and execution in high-margin segments like cognitive health services.

Sources

Company filings, Bloomberg

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2026202720282029203020312032203320342035203620372038203920402041204220432044204520462047204820492050

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount